Selene Therapeutics

Selene Therapeutics is at the forefront of biotechnology, pioneering innovative solutions in the treatment of refractory epilepsy. Focused on regulating neuronal activity, Selene Therapeutics is developing a novel therapeutic strategy that aims to improve patient outcomes by reducing the neuronal mean firing rate (MFR). This approach holds significant promise for individuals seeking advanced treatment options for epilepsy.

Located at Ilan Ramon 2, Ness Ziona, IL, Selene Therapeutics is dedicated to advancing the science of neurological therapies. Through rigorous research and development, Selene Therapeutics is committed to creating impactful treatments that address unmet medical needs in the field of epilepsy. The company's focus on precision and innovation drives its mission to enhance the quality of life for patients.

Selene Therapeutics is poised to make significant contributions to the biotechnology landscape with its specialized focus on epilepsy. As the company continues to grow and evolve, it remains dedicated to scientific excellence and the development of groundbreaking therapies. We invite the management of Selene Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.